Tanveer K. Chaudhry, MD, joins Fox Chase and Jeanes Hospital as an attending physician in the anesthesiology medical team. After receiving her MD from the University of Akron, she did a year’s residency at Philadelphia’s Thomas Jefferson University Hospital and then completed residency training in anesthesiology at The Johns Hopkins Hospital in Baltimore. She was also a critical care fellow at the University of Pennsylvania.
Elias Obeid, MD, MPH, who specializes in breast and ovarian cancer risk assessment and in the treatment of patients with breast cancer, joins the department of clinical genetics as an attending physician. Previously an instructor at the University of Chicago, he received his MD from the American University of Beirut School of Medicine and his MPH from the University of Massachusetts, Amherst.
Steven J. Mattleman, MD, FACC, has joined Fox Chase’s department of medicine as director of the division of cardiology. He will also continue his practice as a cardiologist with Pennsylvania Heart and Vascular – Temple Health. Mattleman received his MD from Hahnemann Medical College in Philadelphia, where he also served as chief resident and chief cardiology fellow.
Suzanne Ben-Kane, MD, MPH, joins Fox Chase as a hospitalist. She received her MD from the University of Debrecen Medical and Health Science Centre in Debrecen, Hungary, and her MPH from the University of Debrecen School of Public Health. Ben-Kane completed her internal medicine residency at Abington Memorial Hospital in Pennsylvania.
Henry C. Fung, MD, an internationally recognized leader in the field of blood diseases and bone marrow transplantation, joins Fox Chase as clinical leader of the blood cancers program and the hematologic oncology service line, and a professor of medical oncology. He will also direct the Temple University Hospital Bone Marrow Transplant Program. Fung has held faculty and research positions at several distinguished cancer centers, including City of Hope Comprehensive Cancer Center and the Chao Family Comprehensive Cancer Center of the University of California, Irvine. He graduated from The Chinese University of Hong Kong’s school of medicine and interned at its Prince of Wales Hospital, did his residency and fellowship at Hong Kong University’s Queen Mary Hospital, and completed a Hematologic Oncology/Bone Marrow Transplant fellowship at the British Columbia Cancer Control Agency in Vancouver, Canada. Read a Q&A with Dr. Fung.
Jennifer Y. Shih, MD, MS, joins the department of medical oncology and the breast cancer treatment team as an attending physician after completing a fellowship in hematology/oncology at the University of Virginia Medical Center. She earned her MD at Taipei Medical University in Taiwan and did her internal medicine residency at Abington Memorial Hospital in Pennsylvania.
Yanis Boumber, MD, PhD, joins the department of medical oncology as an attending physician after completing clinical and research fellowships at the University of Texas MD Anderson Cancer Center in Houston. Boumber, who specializes in treating patients with thoracic cancers, including lung cancer, thymoma, and mesothelioma, earned his MD from Russia’s Rostov State Medical University and his doctorate from the University of Texas Graduate School of Biomedical Sciences. Boumber completed an internal medicine residency at Johns Hopkins University’s Good Samaritan Hospital in Baltimore.
Nadia Khan, MD, comes to Fox Chase following a medical oncology fellowship at Georgetown University in Washington, DC. She received her MD from Temple University School of Medicine in Philadelphia, where she also completed her residency. Khan, who will treat patients with and conduct clinical research on malignant lymphoma, has joined the department of medical oncology as an attending physician.
Robert Carlson, MD, CEO of the National Comprehensive Cancer Network (NCCN) and a leading medical oncologist focusing on breast cancers, has joined Fox Chase’s department of medical oncology in a part-time capacity as an attending physician. Prior to assuming the top leadership role at the NCCN, Carlson was medical director of inpatient oncology and hematology at the Stanford Cancer Institute, and professor of medicine in the division of oncology at Stanford University Medical Center.
Susan Copley Cobb, RN, MSN, PhD, is the new director of professional development and practice innovation at Fox Chase and Jeanes Hospital. Previously at the Hospital of the University of Pennsylvania, she is also an adjunct professor of graduate nursing education at Excelsior College in Albany. She received her PhD from Pittsburgh’s Duquesne University, her MSN from the University of Pennsylvania, and her BSN from Binghamton University.
James Duncan, PhD, joins the Cancer Biology Program as an assistant professor after completing his postdoctoral fellowship in the department of pharmacology at the University of North Carolina. Duncan received his PhD from the University of Western Ontario, Canada. He has expertise in signal transduction, particularly the role of protein kinase networks in breast cancer.
Vasily M. Studitsky, PhD, has joined Fox Chase as a professor and co-leader of the Cancer Epigenetics Program. An internationally recognized expert in epigenetics, Studitsky most recently served as a professor at the Robert Wood Johnson Medical School of Rutgers in New Brunswick, New Jersey, as well as Wayne State University School of Medicine in Detroit. Studitsky received his MS in biochemistry from Moscow State University and his PhD from the W. Engelhardt Institute of Molecular Biology in Moscow, Russia. Studitsky completed his postdoctoral fellowship at the National Institutes of Health, where he conducted research on transcription through chromatin by model bacteriophage SP6 RNA polymerase and yeast RNA polymerase III.
Neil Johnson, PhD, whose research focuses on homologous recombination in breast and ovarian cancer, has joined the Developmental Therapeutics Program as an assistant professor. Before completing postdoctoral training at Dana-Farber Cancer Institute in Boston, Johnson received both his BS in Genetics and his PhD in Cancer Biology/Therapeutics from the University of Newcastle upon Tyne, United Kingdom.